Tavaborole
NDC 70771-1826, Tavaborole, solution, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1826
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212294
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1826 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAVABOROLE43.5 mg/mL
Pharmacologic classes
Boron Compounds [CS]; Oxaborole Antifungal [EPC]; Protein Synthesis Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1826-0 | 70771182600 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (70771-1826-0) / 10 mL in 1 BOTTLE, WITH APPLICATOR |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/15bc62dc-4f5e-4d43-a125-d1f00bee84a5
Use it
Look up 70771-1826 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1826 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1826. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.